Endurance Wealth Management, Inc. Gsk PLC Transaction History

Endurance Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	BUY	$32.47 - $48.83 $6,494 - $9,766	200 Added 37.45%	734 $28,000
Q4 2018 Jan 14, 2019	SELL	$37.8 - $42.69 $5,405 - $6,104	-143 Reduced 21.12%	534 $20,000
Q2 2018 Aug 02, 2018	SELL	$39.61 - $42.76 $3,366 - $3,634	-85 Reduced 11.15%	677 $27,000
Q4 2017 Jan 18, 2018	SELL	$35.34 - $41.9 $4,629 - $5,488	-131 Reduced 14.67%	762 $27,000
Q3 2017 Oct 19, 2017	BUY	$39.44 - $41.55 $35,219 - $37,104	893	893 $36,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Endurance Wealth Management, Inc. with notifications on news.